Literature DB >> 27468066

Defining Metastatic Cell Latency.

Jeffrey W Pollard1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27468066      PMCID： PMC5024542          DOI： 10.1056/NEJMcibr1606716

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT.

Authors:  Srinivas Malladi; Danilo G Macalinao; Xin Jin; Lan He; Harihar Basnet; Yilong Zou; Elisa de Stanchina; Joan Massagué
Journal:  Cell       Date:  2016-03-24       Impact factor: 41.582

2.  CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.

Authors:  Bin-Zhi Qian; Jiufeng Li; Hui Zhang; Takanori Kitamura; Jinghang Zhang; Liam R Campion; Elizabeth A Kaiser; Linda A Snyder; Jeffrey W Pollard
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

Review 3.  Advantages and clinical applications of natural killer cells in cancer immunotherapy.

Authors:  Erik Ames; William J Murphy
Journal:  Cancer Immunol Immunother       Date:  2013-08-30       Impact factor: 6.968

4.  Patrolling monocytes control tumor metastasis to the lung.

Authors:  Richard N Hanna; Caglar Cekic; Duygu Sag; Robert Tacke; Graham D Thomas; Heba Nowyhed; Erica Herrley; Nicole Rasquinha; Sara McArdle; Runpei Wu; Esther Peluso; Daniel Metzger; Hiroshi Ichinose; Iftach Shaked; Grzegorz Chodaczek; Subhra K Biswas; Catherine C Hedrick
Journal:  Science       Date:  2015-10-22       Impact factor: 47.728

Review 5.  Immune cell promotion of metastasis.

Authors:  Takanori Kitamura; Bin-Zhi Qian; Jeffrey W Pollard
Journal:  Nat Rev Immunol       Date:  2015-02       Impact factor: 53.106
  5 in total
  4 in total

Review 1.  Of Cytometry, Stem Cells and Fountain of Youth.

Authors:  Dariusz Galkowski; Mariusz Z Ratajczak; Janusz Kocki; Zbigniew Darzynkiewicz
Journal:  Stem Cell Rev Rep       Date:  2017-08       Impact factor: 5.739

Review 2.  Metastatic Latency, a Veiled Threat.

Authors:  Kangsan Kim; Mauricio Marquez-Palencia; Srinivas Malladi
Journal:  Front Immunol       Date:  2019-08-06       Impact factor: 7.561

3.  Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours.

Authors:  Ellen Brenner; Barbara F Schörg; Fatima Ahmetlić; Thomas Wieder; Franz Joachim Hilke; Nadine Simon; Christopher Schroeder; German Demidov; Tanja Riedel; Birgit Fehrenbacher; Martin Schaller; Andrea Forschner; Thomas Eigentler; Heike Niessner; Tobias Sinnberg; Katharina S Böhm; Nadine Hömberg; Heidi Braumüller; Daniel Dauch; Stefan Zwirner; Lars Zender; Dominik Sonanini; Albert Geishauser; Jürgen Bauer; Martin Eichner; Katja J Jarick; Andreas Beilhack; Saskia Biskup; Dennis Döcker; Dirk Schadendorf; Leticia Quintanilla-Martinez; Bernd J Pichler; Manfred Kneilling; Ralph Mocikat; Martin Röcken
Journal:  Nat Commun       Date:  2020-03-12       Impact factor: 14.919

4.  FBX8 promotes metastatic dormancy of colorectal cancer in liver.

Authors:  Xiaohui Zhu; Feifei Wang; Xuehui Wu; Zhou Li; Zhizhi Wang; Xiaoli Ren; Yangshu Zhou; Fuyao Song; Yunshi Liang; Zhicheng Zeng; Wangjun Liao; Yanqing Ding; Wenting Liao; Li Liang
Journal:  Cell Death Dis       Date:  2020-08-14       Impact factor: 8.469
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.